South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Report Overview

Table of Contents

958.01

Select License Type

£958.01	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,916.01	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£2,874.02	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£958.01	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Chemicals
Report Type	Market Research
Country	South America
Published	27 August 2009
Number of Pages	75
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct
File Format	-

In 2009, the South and Central American API market is set to grow at a rate of around 2%

The new report "South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020" provides in-depth analysis of the South and Central American Active Pharmaceutical Ingredients (API) market and presents revenue forecasts up to 2020 for Mexico and Brazil. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base – generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole South and Central American market is also covered in the report.

Economic Crisis Slows the Revenue Growth of the South and Central American API Market

The current global economic crisis has negatively affected the South and Central American API market leading to a drastic reduction in its growth. The economic crisis has necessitated the need for the governments to reduce their expenditure even in the healthcare sector. Therefore, in an attempt to realize significant savings in healthcare expenditure, there is a shift away from the high-priced innovative drugs in Mexico and Brazil. This has resulted in a significant slowdown in the revenue growth of the South and Central American API market. In 2009, the South and Central American API market is set to grow at a rate of around 2%.

Brazil Set to Overtake Mexico in the South and Central American API Market by 2020

The Brazilian API market, the second largest market in South and Central America, is set to overtake Mexico in its revenue share by 2020. The Brazilian API market is characterized by an emerging biotech API product segment which is the fastest growing in the South and Central American market. Adding to this, the Brazilian pharmaceutical industry is strong and growing at a healthier rate than Mexico and other countries. This higher growth is set to enable the Brazilian API market to gain revenue share during the period 2008-2020. By 2020, Brazil is expected to hold a revenue share of around 30% and Mexico around 28%.

Biotech APIs Set to Drive the Overall Growth of the API Market in South and Central America

The biotech API market in South and Central America is geared for a higher growth which is set to drive the overall growth of the API market. The increasing demand for biological drugs is boosting the demand for the biotech API in the market place. In addition, the technological advancement in the pharmaceutical industry is paving the way for newer biotechnology drugs. This will boost the growth of the biotech API market making it grow at a rate which is significantly higher than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 7% from 2008 to 2020.

Generic APIs Get a Boost Due to the Cost-Containment Measures in South and Central America

The generic APIs in the South and Central American API market are witnessing increased growth as a result of the cost-containment measures being followed in the region. Primarily, the API market in South and Central America has been driven by the innovative sector. However, the expensive nature of these drugs, that increase the overall healthcare expenditure of the country, has compelled the government to implement steps to accelerate the growth of the generic sector. The low-priced generic drugs enable a cost reduction of around 30-40% and therefore has gained increased acceptance in the wake of recession. As a result of such aggressive measures to boost the growth of the generic drugs in the South and Central American region, the under-developed generic API market is expected to get a stronger boost in its growth. Generic APIs are expected to grow at a CAGR of around 7% from 2008 to 2020 which is significantly higher than that of the innovative sector which is set to grow at a modest rate of 2% for the same time period in South and Central America.

The new report "South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020" provides in-depth analysis of the South and Central American API market with revenue forecasts up to 2020. The revenue forecasts, which include historical statistics of the market, are provided for the countries – Brazil and Mexico . The factors that drive and restrain the growth of the API market in South and Central America are also analyzed in the report. In addition, the research provides the market share analysis of the leading API producers in the region. The market for each country is analyzed based on product types and customer base.

Scope

- Market revenues data from 2000 to 2008 and forecast for 12 years to 2020.
- API market in key countries – Mexico and Brazil.
- Coverage of the two major product segments of the API market in South and Central America – Synthetic and Biotech API.
- The two broad market sectors for synthetic APIs based on customer base, generic and innovative, have been included and revenue forecasts and analysis is provided for Mexico and Brazil.
- Drivers such as increasing demand for generic and biotech drugs and restraints such as the economic recession and price erosion for the South and Central American API market are also analyzed in the report.
- Information on the competitive landscape with the revenue shares of the leading companies such as Lonza, DSM, and Evonik Degussa.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the API market in South and Central America.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the API market in South and Central America.
- Capitalize by identifying the API market segments poised for strong growth.
- Identify macro and micro-economic trends shaping and driving the API market in the region.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£958.01	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,916.01	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£2,874.02	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£958.01	Add to Wishlist
Change Currency	GBP EURO USD

1 Table Of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is this Report About? 9
2.2 GMD Report Coverage 9
3 Executive Summary 10
3.1 Market Introduction and Overview 10
3.2 Industry Challenges 10
3.3 Market Drivers 10
3.4 Market Restraints 11
3.5 Total Market Revenue Forecasts 11
3.6 Revenue Share Analysis by Product Types 12
3.7 Competitive Landscape 13
3.8 Conclusion 13
4 South and Central America Active Pharmaceutical Ingredients Market 14
4.1 Market Overview 14
4.2 Product Types 15
4.2.1 Types Based on Synthesis Routes 15
4.2.2 Types based on Customer Base 16
4.3 Industry Structure 16
4.4 Industry Challenges 17
4.4.1 Regulatory Challenges Lead to Delay in Launch of the Drugs in the Market 17
4.4.2 Price Reductions Lead to Shrinking Margins for the API Producers in South and Central America 17
4.5 Market Drivers 18
4.5.1 Growth in Pharmaceutical Industry Keeps the API Market Growing in South and Central America 18
4.5.2 Generic Sector Augments the Growth of API Market in South and Central America 19
4.5.3 Biotechnology a Significant Growth Driver for the South and Central American API Market 20
4.6 Market Restraints 20
4.6.1 Slowdown in Innovative Sector Bound to Hamper the growth of the South and Central American API Market 20
4.6.2 Current Economic Crisis Slows the Growth of the API Market in South and Central America 20
4.6.3 Declining Prices Erode the Revenue Growth of the South and Central API Market 20
4.7 Total Revenue Forecasts 21
4.8 Analysis by Product Types Based on Synthesis Routes 22
4.8.1 Revenue Share Analysis 22
4.8.2 South and Central America Synthetic API Market Analysis 24
4.8.3 South and Central America Biotech API Market Analysis 29
4.8.4 Revenue Share Trend Analysis 36
4.9 Analysis of Synthetic API Market by Customer Base 37
4.9.1 Revenue Share Analysis 37
4.9.2 South and Central America Synthetic Innovative API Market Analysis 38
4.9.3 South and Central America Synthetic Generic API Market Analysis 44
4.9.4 Revenue Share Trend Analysis 50
4.10 Analysis by Countries 51
4.11 Competitive Landscape 54
4.12 Market Share Analysis 55
5 Mexico Active Pharmaceutical Ingredients Market 56
5.1 Market Introduction and Overview 56
5.2 Market Drivers 56
5.2.1 Growth in Pharmaceutical Industry Drives the Overall Growth of the API Market in Mexico 56
5.2.2 Generics Augment the Growth of the Mexican API Market 56
5.3 Market Restraints 56
5.3.1 Decreasing Focus on Innovative Sector Reduces the Growth of API Market in Mexico 56
5.3.2 Economic Recession Slows the Growth of API Market 56
5.4 Total Revenue Forecasts 57
5.5 Revenue Share Analysis by Product Types 59
5.6 Revenue Forecasts of Synthetic API by Customer Base 60
5.7 Revenue Share Analysis of Synthetic API by Customer Base 62
6 Brazil Active Pharmaceutical Ingredients Market 64
6.1 Market Introduction and Overview 64
6.2 Market Drivers 64
6.2.1 Generic Drugs Sector Boosts the Growth of the Brazilian API Market 64
6.2.2 Ageing Population Drives the Sales of API in Brazil 64
6.2.3 Increasing Focus on Biotechnology Drives the Growth of API Brazilian API Market 64
6.3 Market Restraints 64
6.3.1 Economic Recession Hampers the Growth of API Market in Brazil 64
6.3.2 Reducing Demand for the Innovative APIs Slows the Growth of the Brazilian API Market 65
6.4 Total Revenue Forecasts 65
6.5 Revenue Share Analysis by Product Types 68
6.6 Revenue Forecasts of Synthetic API by Customer Base 69
6.7 Revenue Share Analysis of Synthetic API by Customer Base 71
7 Appendix 73
7.1 Methodology 73
7.1.1 Coverage 73
7.1.2 Secondary Research 74
7.1.3 Primary Research 74
7.1.4 Expert Panel Validation 75
7.2 Unit of Measure 75
7.3 Contact Us 75
7.4 About Global Markets Direct 75
7.5 Disclaimer 75

1.1 List of Tables
Table 1: South and Central America API Market, Revenue Forecasts, 2000-2020 21
Table 2: South and Central America, Revenue Share Analysis by Product Types, 2008 23
Table 3: South and Central America Synthetic API Market, Revenue Forecasts, 2000-2020 25
Table 4: South and Central America Synthetic API Market, Revenue Share Analysis by Countries, 2008 27
Table 5: South and Central America Biotech API Market, Revenue Forecasts, 2000-2020 31
Table 6: South and Central America Biotech API Market, Revenue Share Analysis by Countries, 2008 33
Table 7: South and Central America Synthetic API Market, Revenue Share Analysis by Customer Base, 2008 37
Table 8: South and Central America Synthetic Innovative API Market, Revenue Forecasts, 2000-2020 39
Table 9: South and Central America Synthetic Innovative API Market, Revenue Share Analysis by Countries, 2008 41
Table 10: South and Central America Synthetic Generic API Market, Revenue Forecasts, 2000-2020 45
Table 11: South and Central America Synthetic Generic API Market, Revenue Share Analysis by Countries, 2008 47
Table 12: South and Central America API Market, Revenue Share Analysis by Countries, 2008 51
Table 13: Mexico API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020 57
Table 14: Mexico API Market, Revenue Share Analysis by Product Types Based on Synthesis Routes, 2000-2020 59
Table 15: Mexico Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 60
Table 16: Mexico Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020 62
Table 17: Brazil API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020 65
Table 18: Brazil API Market, Revenue Share Analysis by Product Types, 2000-2020 68
Table 19: Brazil Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 69
Table 20: Brazil Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020 71

1.2 List of Figures
Figure 1: South and Central America API Market, Revenue Forecasts, 2000-2020 11
Figure 2: South and Central America API Market, Revenue Share Analysis by Product Types, 2008 12
Figure 3: South and Central America API Market, Product Types 15
Figure 4: South and Central America API Market, Value Chain, 2008 16
Figure 5: South and Central America API Market, Market Drivers and Restraints, 2009-2020 18
Figure 6: South and Central America API Market, Population Growth by Countries, 2005-2025 19
Figure 7: South and Central America API Market, Revenue Forecasts, 2000-2020 22
Figure 8: South and Central America, Revenue Share Analysis by Product Types, 2008 23
Figure 9: South and Central America Synthetic API Market, Revenue Forecasts, 2000-2020 26
Figure 10: South and Central America Synthetic API Market, Revenue Share Analysis by Countries, 2008 27
Figure 11: South and Central America Synthetic API Market, Growth Rate Comparison of Countries, 2008-2020 28
Figure 12: South and Central America Synthetic API Market, Revenue Share Trend Analysis by Countries, 2008-2020 29
Figure 13: South and Central America Biotech API Market, Revenue Forecasts, 2000-2020 32
Figure 14: South and Central America Biotech API Market, Revenue Share Analysis by Countries, 2008 33
Figure 15: South and Central America Biotech API Market, Growth rate Comparison of Countries, 2008-2020 34
Figure 16: South and Central America Biotech API Market, Revenue Share Trend Analysis by Countries, 2000-2020 35
Figure 17: South and Central America API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 36
Figure 18: South and Central America Synthetic API Market, Revenue Share Analysis by Customer Base, 2008 38
Figure 19: South and Central America Synthetic Innovative API Market, Revenue Forecasts, 2000-2020 40
Figure 20: South and Central America Synthetic Innovative API Market, Revenue Share Analysis by Countries, 2008 41
Figure 21: South and Central America Synthetic Innovative API Market, Revenue Share Analysis by Countries, 2008 42
Figure 22: South and Central America Synthetic Innovative API Market, Revenue Share Trend Analysis by Countries, 2008 43
Figure 23: South and Central America Synthetic Generic API Market, Revenue Forecasts, 2000-2020 46
Figure 24: South and Central America Synthetic Generic API Market, Revenue Share Analysis by Countries, 2008 47
Figure 25: South and Central America Synthetic Generic API Market, Revenue Share Trend Analysis by Countries 48
Figure 26: South and Central American Synthetic Generic API Market, Revenue Share Trend Analysis by Countries, 2000-2020 49
Figure 27: South and Central America Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 50
Figure 28: South and Central America API Market, Revenue Share Analysis by Countries, 2008 51
Figure 29: South and Central America API Market, Revenue Growth Rate Comparison by Countries, 2008-2020 52
Figure 30: South and Central American API Market, Revenue Share Trend Analysis by Countries, 2000-2020 53
Figure 31: South and Central America API Market, Competitive Factors, 2009-2020 54
Figure 32: South and Central America API Market, Revenue Share Analysis by Companies 55
Figure 33: Mexico API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020 58
Figure 34: Mexico API Market, Revenue Share Analysis by Product Types Based on Synthesis Routes, 2000-2020 59
Figure 35: Mexico Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 61
Figure 36: Mexico Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020 63
Figure 37: Brazil API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020 67
Figure 38: Brazil API Market, Revenue Share Analysis by Product Types, 2000-2020 68
Figure 39: Brazil Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 70
Figure 40: Brazil Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020 72
Figure 41: Global Markets Direct Methodology 73

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

South American Release Liner Outlook 2009

Sophistication and Evolution in Men's Grooming Products

Solar Power - India

Solar Photovoltaic Cell Market Report: 2010 Edition

Chemicals Company Profiles

Find Chemicals Company Profiles, with SWOT analysis and latest financials.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Chemicals	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Select License Type

In 2009, the South and Central American API market is set to grow at a rate of around 2%

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Chemicals Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel